Patent classifications
A01N35/02
MICROBICIDAL COMPOSITION
A synergistic microbicidal composition having two components. The first component is a nonionic surfactant with structure: R.sup.2O(CH.sub.2CH(CH.sub.3)O).sub.3(CH.sub.2CH.sub.2O).sub.7H, where R.sup.2 is a mixture of C.sub.8-C.sub.14 linear alkyl groups. The second component is tris(hydroxymethyl)nitromethane. The weight ratio of the nonionic surfactant to tris(hydroxymethyl)nitromethane is from 1:0.16 to 1:1.8286.
MICROBICIDAL COMPOSITION
A synergistic microbicidal composition having two components. The first component is a nonionic surfactant with structure: R.sup.2O(CH.sub.2CH(CH.sub.3)O).sub.3(CH.sub.2CH.sub.2O).sub.7H, where R.sup.2 is a mixture of C.sub.8-C.sub.14 linear alkyl groups. The second component is tris(hydroxymethyl)nitromethane. The weight ratio of the nonionic surfactant to tris(hydroxymethyl)nitromethane is from 1:0.16 to 1:1.8286.
A COMPOSITION AND METHOD FOR THE REMOVAL OF BIOFILM
The present invention relates to a synergistic composition and method for removing biofilm using glutaraldehyde and analogs of mannose.
A COMPOSITION AND METHOD FOR THE REMOVAL OF BIOFILM
The present invention relates to a synergistic composition and method for removing biofilm using glutaraldehyde and analogs of mannose.
A COMPOSITION AND METHOD FOR THE REMOVAL OF BIOFILM
The present invention relates to a synergistic composition and method for removing biofilm using glutaraldehyde and analogs of mannose.
Extended release plastic formulation
A plastic material for extended release of a bio-active agent, the plastic material comprising a structural polymer, at least one bio-active ingredient embedded within the structural polymer as solid islands, a liquid binding material embedded within the structural polymer as granules, and a carrier liquid absorbed within the liquid-absorbent material. The carrier liquid may be sufficiently non-compatible with the structural polymer so that at least a portion of the carrier liquid is released from the liquid-absorbent material through the structural polymer to an outer surface of the plastic material over a period of time, such as a week or more, a month or more, or about three months. The bio-active agent comprised in the at least one bio-active ingredient may be sufficiently soluble in the carrier liquid at room or body temperature so that the carrier liquid released to the outer surface comprises the bio-active agent in solution.
Extended release plastic formulation
A plastic material for extended release of a bio-active agent, the plastic material comprising a structural polymer, at least one bio-active ingredient embedded within the structural polymer as solid islands, a liquid binding material embedded within the structural polymer as granules, and a carrier liquid absorbed within the liquid-absorbent material. The carrier liquid may be sufficiently non-compatible with the structural polymer so that at least a portion of the carrier liquid is released from the liquid-absorbent material through the structural polymer to an outer surface of the plastic material over a period of time, such as a week or more, a month or more, or about three months. The bio-active agent comprised in the at least one bio-active ingredient may be sufficiently soluble in the carrier liquid at room or body temperature so that the carrier liquid released to the outer surface comprises the bio-active agent in solution.
PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER
A method for providing a bio-active layer on a surface, includes the steps of: a) ionizing a plasma gas at low temperature of 150° C. or lower, and at about atmospheric pressure, thereby creating a plasma; b) introducing a precursor into said plasma; c) exposing the surface to said plasma comprising said precursor, thereby forming a coating onto the surface. The precursors include a biological pathogen transfer inhibiting compound.
PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER
A method for providing a bio-active layer on a surface, includes the steps of: a) ionizing a plasma gas at low temperature of 150° C. or lower, and at about atmospheric pressure, thereby creating a plasma; b) introducing a precursor into said plasma; c) exposing the surface to said plasma comprising said precursor, thereby forming a coating onto the surface. The precursors include a biological pathogen transfer inhibiting compound.
Method and Composition for Treating Ringworm on Biotic and Abiotic Surfaces
Embodiments of the disclosure relate to treatments for ringworm on biotic and abiotic surfaces. According to one aspect, a concentrated antimicrobial solution is provided. The concentrated solution includes an antimicrobial composition, a solubilizing agent, and an essential oil. The concentrated antimicrobial solution can be mixed with water, and the resulting solution can be used to disinfect abiotic surfaces from ringworm. According to another aspect, an antimicrobial cream is provided. The antimicrobial cream includes a carrier including a humectant and an antimicrobial composition dispersed in the carrier at 1% w/v or greater.